- Home
- Applications
- platelet
Refine by
Platelet Product Applications For The Served Medical Health Care Industry
9 applications found
Growth performance of Madin-Darby canine kidney (MDCK NBL-2) cells in media containing Simplified Platelet Lysate (SimPL), fetal bovine serum (FBS), or human platelet lysate (hPL). ...
ByAgulos Biotech, LLC based in Lake Mills, WISCONSIN (USA)
Growth of FO myeloma cells in media containing Simplified Platelet Lysate (SimPL-Serum) and fetal bovine serum (FBS). Cells were grown in standard DMEM basal media containing penicillin, streptomycin, and GlutaMAX™ with 10% (v/v) FBS or 10% SimPL-Serum in 6-well plates. ...
ByAgulos Biotech, LLC based in Lake Mills, WISCONSIN (USA)
Collagen fibrils in collagen powder helps to trap platelets and assist in forming a clot to stop bleeding. Extracellular matrix scaffolds are widely used in hernia repair and other areas of soft tissue weakness. ...
ByViscus Biologics LLC based in Cleveland, OHIO (USA)
Growth performance of 3T3-L1 fibroblasts in media containing Simplified Platelet Lysate (SimPL) and fetal bovine serum (FBS). 3T3-L1 fibroblasts were grown in DMEM/F12 basal media containing penicillin, streptomycin, and GlutaMAX™ with either 10% (v/v) FBS or 10% SimPL. ...
ByAgulos Biotech, LLC based in Lake Mills, WISCONSIN (USA)
Growth performance of human adipose-derived mesenchymal stem cells in media containing Simplified Platelet Lysate (SimPL) and fetal bovine serum (FBS). Cells were grown in standard DMEM/F12 basal media containing penicillin, streptomycin, and GlutaMAX™ with either 10% (v/v) FBS or 2% SimPL (left). ...
ByAgulos Biotech, LLC based in Lake Mills, WISCONSIN (USA)
We adapted an autologous ex-vivo gene therapy method to load the patient’s own TEMs precursors, that are hematopoietic stem and progenitor cells (HSPCs), with an immunotherapeutic transgene sequence. By re-introducing gene-modified HSPCs into the patient, we seek to take advantage of the self-renewing and multi-differentiation capability of HSPCs to enable durable and potentially long-term effects following a single ...
ByGenenta Science based in Milano, ITALY
Preventative care for obstetric related venous thromboembolism (VTE). Pulmonary embolism (PE) is the leading cause of maternal death in the developed world. Patients are 5 times more likely to develop deep vein thrombosis (DVT) during pregnancy2. The UK incidence of VTE in pregnancy and the puerperium is 1–2 episodes per 1,000 patients3 and accounts for 10% of all maternal deaths in the United ...
ByFirstkind Ltd based in High Wycombe, UNITED KINGDOM
Traditionally, primary treatment for DVT has focused on anticoagulation, rather than thrombus removal. Anticoagulation therapy does not remove existing thrombus but rather prevents the propagation of the ...
BySurmodics, Inc. based in Eden Prairie, MINNESOTA (USA)
Endovascular clot removal methods can provide immediate symptom relief and, by removing clot early, physicians can identify an underlying obstructive lesion that may require a stent. Current endovascular treatment methods involve catheter-directed thrombolysis (CDT), percutaneous mechanical thrombectomy (PMT), balloon venoplasty, iliac vein stenting, and manual ...
BySurmodics, Inc. based in Eden Prairie, MINNESOTA (USA)